Report Categories
View AllRecent Articles
View All
What German GABC does that creates lasting value 111 20260508
Aemetis AMTX Stock Why the Market Watches It Momentum Fading 20260418
NewcelX NCEL Stock Equalweight Runs Up 20260418
Ford Motor Company F
Deckers DECK Stock Analysis Undervalued or Overpriced Momentum Fading 20260420
Progress PRGS Active Stock Progress meets EPS estimates with solid Q1 revenue
Dollar General Corporation DG Assessing Downside Risks Amid the Widening Wall StreetMain Street Sentiment Divide
What Belden BDCs 342 Decline Means for Investors 20260515
Sezzle SEZL Q1 2026 Earnings Surprise EPS 147 Up Significant
NPR Restructures Newsroom Amid Shift Away from Public Funding
Wholesale Inflation Surges 6 in April Marking Sharpest Annual Gain Since 2022
Celsius CELH Q1 2026 Earnings EPS 041 Beats Estimates
PGIM GHY Stalls at 1202 Consolidation Phase 20260514
AIDriven Layoffs Stock Boost May Be Illusory Data Suggests
NASA Selects Blue Origin for First Uncrewed Lunar Mission in 20 Billion Moon Base Plan
Everlane Founder Michael Preysman Announces New Venture After Shein Acquisition
Autodesk Q1 Earnings Preview Market Awaits Key Metrics and Guidance
The Federal Funds Rate Explained How Fed Policy Shapes Your Finances
Kiplinger Retail Outlook Consumer Spending Holds Strong but Future Uncertainties Mount
Quantum Biopharma Ltd QNTM Q4 2025 Earnings Biotech Reports Wider Loss Amid Strategic Progress Stock Jumps 18
FICO Q1 2026 Earnings EPS Surges 1165 Above Estimates Shares Rise
PTHS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares
ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress
APPN Q1 2026 Earnings EPS Surge Beats Estimates by 44
IAC Q1 2026 Earnings Steep EPS Miss Overshadowed by Modest Stock Gain
Permian Resources PR Holds Steady at 1932 as RangeBound Trading Continues
DarioHealth DRIO Sheds 116 as Stock Tests Key Support Levels
TFS Financial Corporation TFSL Holds Steady Near Resistance Potential for Breakout or Reversal
Revvity Inc RVTY Gains 165 as Price Approaches Key Resistance
ArriVent BioPharma AVBP Eases 168 Support at 261 in Focus After Sector Headwinds